Cargando…

Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment

BACKGROUND: (Auto)immune mediated and cholestatic liver disease (AILD) includes autoimmune hepatitis (AIH), primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Especially AIH is characterized by the presence of autoantibodies and elevated serum immunoglobulins. In rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Beukel, Michelle D., Stoelinga, Anna E. C., van der Meer, Adriaan J., van der Meulen, Stef, Zhang, Lu, Tushuizen, Maarten E., van Hoek, Bart, Trouw, Leendert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411548/ https://www.ncbi.nlm.nih.gov/pubmed/37564051 http://dx.doi.org/10.3389/fmed.2023.1195747

Ejemplares similares

Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment
por: van den Beukel, Michelle D., et al.
Publicado: (2023)

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
por: Biewenga, Maaike, et al.
Publicado: (2022)

Early Predictors of Short‐Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis
por: Biewenga, Maaike, et al.
Publicado: (2020)

Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis: A Systematic Review
por: Baven-Pronk, Martine AMC, et al.
Publicado: (2022)

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations
por: Monahan, Rory C, et al.
Publicado: (2022)

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands
por: van den Brand, Floris F., et al.
Publicado: (2018)

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association
por: van den Beukel, Michelle D, et al.
Publicado: (2023)

From Farm to Pharma: An Overview of Industrial Heparin Manufacturing Methods
por: van der Meer, Jan-Ytzen, et al.
Publicado: (2017)

Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial
por: Ruijter, Bastian N., et al.
Publicado: (2022)

Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study
por: Ruijter, Bastian N., et al.
Publicado: (2023)

Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example
por: Boeters, Debbie M., et al.
Publicado: (2018)

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the article by Regueiro et al.
por: van Dijk, Bastiaan T., et al.
Publicado: (2020)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
por: Snijders, Romée J. A. L. M., et al.
Publicado: (2022)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Anti-C1q Autoantibodies, Novel Tests, and Clinical Consequences
por: Mahler, Michael, et al.
Publicado: (2013)

Acute Liver Injury and Acute Liver Failure following Bariatric Surgery
por: van Golen, Rowan F., et al.
Publicado: (2022)

Association between COVID-19 infection at the time of admission for birth and adverse pregnancy outcomes: evolving evidence to aid decision making
por: van der Meulen, Jan, et al.
Publicado: (2021)

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1
por: Biewenga, Maaike, et al.
Publicado: (2021)

Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment
por: Taubert, Richard, et al.
Publicado: (2023)

Refitting the Model for End‐Stage Liver Disease for the Eurotransplant Region
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Joint modeling of liver transplant candidates outperforms the model for end‐stage liver disease: The effect of disease development over time on patient outcome
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
por: Goudsmit, Ben F.J., et al.
Publicado: (2023)

Adverse events related to low dose corticosteroids in autoimmune hepatitis
por: van den Brand, Floris F., et al.
Publicado: (2019)

Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Goudsmit, Ben F.J., et al.
Publicado: (2021)

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis
por: Baven-Pronk, Martine A. M. C., et al.
Publicado: (2018)

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
por: van Son, Koen C., et al.
Publicado: (2023)

Recent advances in managing chronic HCV infection: focus on therapy in patients with severe liver disease
por: Maan, Raoel, et al.
Publicado: (2016)

Treating oxidative stress in heart failure: past, present and future
por: van der Pol, Atze, et al.
Publicado: (2018)

The Dutch version of the Oral Health Impact Profile (OHIP-NL): Translation, reliability and construct validity
por: van der Meulen, Marylee J, et al.
Publicado: (2008)

Companion canines: an under-utilised model to aid in translating anti-metastatics to the clinic
por: van der Weyden, Louise, et al.
Publicado: (2019)

A Shared Drive: Securing Patient Access to High-Cost Medicines
por: van der Ent, Leendert
Publicado: (2017)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting
por: van Heemst, Jurgen, et al.
Publicado: (2015)

Capturing Dynamic Performance in a Cognitive Model: Estimating ACT‐R Memory Parameters With the Linear Ballistic Accumulator
por: van der Velde, Maarten, et al.
Publicado: (2022)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

Individualised Ball Speed Prediction in Baseball Pitching Based on IMU Data
por: Gomaz, Larisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n8tr7q1sefndf2i1svloksth1t